Institutional Ownership
Lisata Therapeutics Inc
CUSIP 128058302COMLSTAQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
31
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Renaissance Technologies LLC | 131.7K | $659.9K |
| 2 | Deltec Asset Management LLC | 90.0K | $450.9K |
| 3 | Rangeley Capital, LLC | 75.0K | $375.8K |
| 4 | Geode Capital Management, LLC | 70.9K | $355.2K |
| 5 | Css LLC/Il | 61.9K | $310.1K |
| 6 | Blackrock, Inc. | 54.9K | $274.8K |
| 7 | Penderfund Capital Management Ltd. | 47.5K | $238.0K |
| 8 | Gts Securities LLC | 31.4K | $157.3K |
| 9 | State Street Corp | 25.3K | $127.0K |
| 10 | Citadel Advisors LLC | 22.7K | $113.6K |